Recent scientific research has revealed that women who used the Depo-Provera birth control shot may be five times more likely to develop a form of brain tumors known as meningioma. Women who were ...

Researchers at the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) have discovered that dogs with meningiomas—the most common type of brain tumor in dogs—live longer if ...

In this retrospective study, seventy patients underwent GKRS for grade 2 meningioma between 2007 and 2016. Tumor recurrence was categorized as local, marginal, or distant. Survival curves were ...

Women across the country are taking legal action against Pfizer, the manufacturer of Depo-Provera, alleging that the company failed to warn about the risks of developing meningiomas — generally ...

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN). Meningiomas, often linked to the loss ...

Lutetium 177 dotatate showed activity and met the PFS end point in patients with surgery- or radiation-refractory grade 2/3 meningioma, per a phase 2 trial presented at ASTRO 2024. TREATMENT WITH ...

Researchers at Baylor College of Medicine and Washington University School of Medicine in St. Louis have identified clinical and genetic predictors of multiply recurrent meningiomas (MRMs), a most ...

A meningioma is a tumor that forms on the membranes that cover the brain and spinal cord just inside the skull. These membranes are called the meninges and consist of three layers. Specifically ...

"We've found a therapy with a meaningful signal for effectiveness and safety for people with refractory meningioma, a condition with no standard treatment options," said Kenneth W. Merrell ...

When it comes to brain tumors, meningioma is one of the most common types. But what exactly is meningioma and how does it develop? Meningioma is a tumor that arises from the meninges, which are ...

Prolonged use of certain drugs containing the hormone progestogen can increase the risk of meningioma - a tumour which is mostly non-cancerous - by up to five-fold, a study found. However ...